Trestle is a startup based in the United States, 1 tracked investor.
Trestle is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Trestle develops bioengineered kidneys intended for transplantation to address donor organ shortages and reduce reliance on dialysis. The company applies biotechnology and human-machine interface approaches to create functional, transplantable kidney tissue.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.